0000899243-20-005308.txt : 20200220
0000899243-20-005308.hdr.sgml : 20200220
20200220164955
ACCESSION NUMBER: 0000899243-20-005308
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200218
FILED AS OF DATE: 20200220
DATE AS OF CHANGE: 20200220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linetsky David
CENTRAL INDEX KEY: 0001776729
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38977
FILM NUMBER: 20635929
MAIL ADDRESS:
STREET 1: C/O PHREESIA, INC.
STREET 2: 432 PARK AVENUE S., 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phreesia, Inc.
CENTRAL INDEX KEY: 0001412408
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 432 PARK AVENUE S.
STREET 2: 12TH FLOOR
CITY: New York
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-747-9959
MAIL ADDRESS:
STREET 1: 432 PARK AVENUE S.
STREET 2: 12TH FLOOR
CITY: New York
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Phreesia Inc
DATE OF NAME CHANGE: 20070914
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-18
0
0001412408
Phreesia, Inc.
PHR
0001776729
Linetsky David
C/O PHREESIA, INC.
432 PARK AVENUE SOUTH, 12TH FLOOR
NEW YORK
NY
10016
0
1
0
0
SVP, Life Sciences
Common Stock
2020-02-18
4
S
0
2844
32.8374
D
86639
D
Common Stock
2020-02-18
4
S
0
344
32.9308
D
86295
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
/s/ Charles Kallenbach by Power of Attorney for David Linetsky
2020-02-19